Peer-reviewed articles

Timmons A, Gooberman-Hill R, Sharp L. The multidimensional nature of the financial and economic burden of a cancer diagnosis on patients and their families: qualitative findings from a country with a mixed public-private healthcare system. Support Care Cancer. 2013;21(1):107-117. doi:10.1007/s00520-012-1498-4

Whynes DK, Sharp L, Cotton SC, et al. Impact of alternative management policies on health-related quality of life in women with low-grade abnormal cervical cytology referred for colposcopy. European Journal of Obstetrics Gynecology and Reproductive Biology. 2013;169(1):88-92. doi:10.1016/j.ejogrb.2013.02.006

Sharp L, Tilson L, Whyte S, et al. Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland. BMC Health Serv Res. 2013;13(1):105. doi:10.1186/1472-6963-13-105

Lloyd SM, Stott DJ, de Craen AJM, et al. Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS ONE. 2013;8(9):e72642. doi:10.1371/journal.pone.0072642

European Colorectal Cancer Screening Guidelines Working Group, von Karsa L, Patnick J, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45(1):51-59. doi:10.1055/s-0032-1325997

Donnelly DW, Hegarty A, Sharp L, et al. The Impact of Adjustment for Socioeconomic Status on Comparisons of Cancer Incidence between Two European Countries. Journal of Cancer Epidemiology. 2013;2013:1-6. doi:10.1155/2013/612514

Sharp L, Cotton S, Thornton A, et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. Eur J Obstet Gynecol Reprod Biol. 2012;165(2):318-325. doi:10.1016/j.ejogrb.2012.08.001

Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41(6):1706-1718. doi:10.1093/ije/dys176

ATHENS Group, McSherry LA, Dombrowski SU, et al. ‘It’s a can of worms’: understanding primary care practitioners’ behaviours in relation to HPV using the theoretical domains framework. Implementation Science. 2012;7(1). doi:10.1186/1748-5908-7-73

Hanly P, Skally M, Fenlon H, Sharp L. Cost-effectiveness of computed tomography colonography in colorectal cancer screening: a systematic review. Int J Technol Assess Health Care. 2012;28(4):415-423. doi:10.1017/S0266462312000542

Comber H, Sharp L, Timmons A, Keane FBV. Quality of rectal cancer surgery and its relationship to surgeon and hospital caseload: a population-based study. Colorectal Dis. 2012;14(10):e692-700. doi:10.1111/j.1463-1318.2012.03145.x

Burns R, Walsh B, Sharp L, O’Neill C. Prostate cancer screening practices in the Republic of Ireland: the determinants of uptake. J Health Serv Res Policy. 2012;17(4):206-211. doi:10.1258/jhsrp.2012.011105

Chang CK, Mulholland HG, Cantwell MM, et al. Vitamin D Receptor Gene Variants and Esophageal Adenocarcinoma Risk: A Population-Based Case–Control Study. J Gastrointest Canc. 2012;43(3):512-517. doi:10.1007/s12029-011-9322-9

Babar M, Ryan AW, Anderson LA, et al. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett’s esophagus and esophageal adenocarcinoma. Am J Gastroenterol. 2012;107(9):1331-1341. doi:10.1038/ajg.2012.134

Tilson L, Sharp L, Usher C, et al. Cost of care for colorectal cancer in Ireland: a health care payer perspective. Eur J Health Econ. 2012;13(4):511-524. doi:10.1007/s10198-011-0325-z

Sant M, Minicozzi P, Lagorio S, et al. Survival of European patients with central nervous system tumors. Intl Journal of Cancer. 2012;131(1):173-185. doi:10.1002/ijc.26335

Crocetti E, Trama A, Stiller C, et al. Epidemiology of glial and non-glial brain tumours in Europe. European Journal of Cancer. 2012;48(10):1532-1542. doi:10.1016/j.ejca.2011.12.013

Sharp L, Cotton S, Thornton A, et al. Which women default from follow-up cervical cytology tests? A cohort study within the TOMBOLA trial. Cytopathology. 2012;23(3):150-160. doi:10.1111/j.1365-2303.2011.00848.x

Lubin JH, Cook MB, Pandeya N, et al. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett’s Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol. 2012;36(3):306-316. doi:10.1016/j.canep.2012.03.001

Glover JA, Bannon FJ, Hughes CM, et al. Increased diagnosis and detection rates of carcinoma in situ of the breast. Breast Cancer Res Treat. 2012;133(2):779-784. doi:10.1007/s10549-012-1975-y

Hanly P, Timmons A, Walsh PM, Sharp L. Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach. Value Health. 2012;15(3):429-436. doi:10.1016/j.jval.2011.12.012

Barron TI, Sharp L, Visvanathan K. Beta-adrenergic blocking drugs in breast cancer: a perspective review. Ther Adv Med Oncol. 2012;4(3):113-125. doi:10.1177/1758834012439738

Oberaigner W, Minicozzi P, Bielska-Lasota M, et al. Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decade. Acta Oncologica. 2012;51(4):441-453. doi:10.3109/0284186X.2011.653437

Kiderlen M, Bastiaannet E, Walsh PM, et al. Surgical treatment of early stage breast cancer in elderly: an international comparison. Breast Cancer Res Treat. 2012;132(2):675-682. doi:10.1007/s10549-011-1892-5

Sharp L, Tilson L, Whyte S, et al. Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy. Br J Cancer. 2012;106(5):805-816. doi:10.1038/bjc.2011.580